Ketamine as an adjuvant to opioids for cancer pain management

被引：0

作者：

Chaudhary, Waqas Ashraf ^{[1
]}

Kennett, Jennifer ^{[1
]}

Bano, Ishrat ^{[1
]}

William, Daniel J. ^{[2
]}

机构：

[1] Univ Leicester, Leicester Royal Infirm, Div Anaesthesia Pain Management & Crit Care, Leicester, Leics, England

[2] Derby Royal Infirm, Leicestershire Pain Management Serv, Derby, England

来源：

ANAESTHESIA PAIN & INTENSIVE CARE | 2012年 / 16卷 / 02期

关键词：

Oncology; Neuropathic pain; WHO analgesic ladder; NMDA receptor; Psychotomimetic side effects; Adenocarcinoma; Palliative care;

D O I：

暂无

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

The management of cancer patient's pain with ketamine as an adjuvant to opioids is presented in case reports of three patients with cancer-related neuropathic pain, in which pain proved untreatable with the usual conventional pain therapies. Ketamine was administered either by intrathecal or oral route, in addition to morphine and the pain was controlled successfully in these patients. No untoward side-effects were noted except drowsiness which responded to a reduction in the opioids dose.

引用

页码：174 / 178

页数：5